scholarly article | Q13442814 |
P2093 | author name string | Kit S Lam | |
Joyce S Lee | |||
Kai Xiao | |||
Juntao Luo | |||
Yuanpei Li | |||
Abby M Gonik | |||
Wenwu Xiao | |||
Rinki G Agarwal | |||
P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging | Q33246431 | ||
Role of surface charge density in nanoparticle-templated assembly of bromovirus protein cages | Q33615019 | ||
A novel size-tunable nanocarrier system for targeted anticancer drug delivery | Q33886700 | ||
Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment | Q34029697 | ||
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. | Q36497423 | ||
Formulation of drugs in block copolymer micelles: drug loading and release | Q36683659 | ||
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells | Q36841577 | ||
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Q37146591 | ||
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer | Q37327582 | ||
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats | Q38548001 | ||
Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles | Q39742676 | ||
Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. | Q39861718 | ||
The effect of surface functionality on cellular trafficking of dendrimers | Q39978998 | ||
Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models | Q40062045 | ||
Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer | Q40203487 | ||
DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers | Q40844139 | ||
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice | Q42723945 | ||
The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. | Q42829655 | ||
Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge | Q43786616 | ||
Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan | Q44955434 | ||
Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles | Q46069080 | ||
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs | Q47350227 | ||
Influence of PAMAM dendrimers on human red blood cells. | Q50798681 | ||
Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). | Q51137239 | ||
Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles | Q83167124 | ||
P433 | issue | 13 | |
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 3435-3446 | |
P577 | publication date | 2011-02-04 | |
P1433 | published in | Biomaterials | Q15751139 |
P1476 | title | The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles | |
P478 | volume | 32 |
Q35932503 | "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo |
Q37060160 | 3D arrays for high throughput assay of cell migration and electrotaxis |
Q37209072 | A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy |
Q51262828 | A Versatile and Clearable Nanocarbon Theranostic Based on Carbon Dots and Gadolinium Metallofullerene Nanocrystals. |
Q36839805 | A formative evaluation of two evidence-based psychotherapies for PTSD in VA residential treatment programs |
Q39456318 | A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin |
Q64917268 | A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy. |
Q41758629 | A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus |
Q34093247 | A smart and versatile theranostic nanomedicine platform based on nanoporphyrin |
Q89736557 | Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand |
Q34524822 | Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells |
Q38864932 | Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease |
Q37013368 | An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity |
Q36381340 | Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells |
Q55084538 | Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. |
Q55030497 | Anticancer nanoparticulate polymer-drug conjugate. |
Q92732850 | Antitumor Features of Vegetal Protein-Based Nanotherapeutics |
Q48089996 | Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas. |
Q28536927 | Assembly of bio-nanoparticles for double controlled drug release |
Q37378292 | Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo |
Q38234567 | Barriers to drug delivery in solid tumors |
Q38814420 | Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents. |
Q35634926 | Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats. |
Q88330747 | Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings |
Q54963271 | Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice. |
Q39443391 | Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment |
Q36703124 | Biomaterial Strategies for Immunomodulation. |
Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
Q57696944 | Carbohydrate biomarker recognition using synthetic lectin mimics |
Q91737225 | Carrier-Free, Dual-Functional Nanorods Via Self-Assembly Of Pure Drug Molecules For Synergistic Chemo-Photodynamic Therapy |
Q46332764 | Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo. |
Q48907844 | Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain |
Q45064544 | Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging |
Q35776325 | Charged group surface accessibility determines micelleplexes formation and cellular interaction |
Q34506844 | Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization |
Q38984345 | Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell |
Q36326103 | Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. |
Q57348235 | Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-cancer efficacy |
Q38889403 | Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles |
Q45035342 | Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis. |
Q35070615 | Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery |
Q64094233 | Controlling nanoemulsion surface chemistry with poly(2-oxazoline) amphiphiles |
Q50543298 | Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy. |
Q37173162 | Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle |
Q90366704 | Critical considerations for targeting colorectal liver metastases with nanotechnology |
Q27002209 | Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines |
Q55383414 | Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs. |
Q91871531 | Current trends and challenges in cancer management and therapy using designer nanomaterials |
Q91272428 | Cysteine immobilisation on the polyethylene terephthalate surfaces and its effect on the haemocompatibility |
Q34567373 | Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics |
Q42099934 | Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells |
Q36028416 | Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma |
Q35998436 | Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer |
Q50901413 | Doxorubicin-loaded micelles based on multiarm star-shaped PLGA-PEG block copolymers: influence of arm numbers on drug delivery. |
Q36106734 | Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer |
Q51465915 | Drug Delivery Vehicles Based on Albumin-Polymer Conjugates. |
Q89858196 | Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer |
Q37257634 | Drug-loadable Mesoporous Bioactive Glass Nanospheres: Biodistribution, Clearance, BRL Cellular Location and Systemic Risk Assessment via (45)Ca Labelling and Histological Analysis |
Q43105872 | Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. |
Q42583845 | Dual secured nano-melittin for the safe and effective eradication of cancer cells |
Q36245928 | Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity. |
Q38837166 | Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery. |
Q37143010 | Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy |
Q36940281 | Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats |
Q27007518 | Efficient hepatic delivery of drugs: novel strategies and their significance |
Q57369923 | Electro-spinning/netting: A strategy for the fabrication of three-dimensional polymer nano-fiber/nets |
Q30939919 | Employing Tryptone as a General Phase Transfer Agent to Produce Renal Clearable Nanodots for Bioimaging |
Q37682915 | Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides |
Q35817956 | Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells |
Q39396904 | Exosomes as Reconfigurable Therapeutic Systems. |
Q46342071 | Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer |
Q37476252 | Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles |
Q38991983 | Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo |
Q38775093 | From structures to functions: insights into exosomes as promising drug delivery vehicles |
Q42530771 | HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy |
Q37445335 | Heterogeneity in nanoparticles influences biodistribution and targeting |
Q51367799 | Hierarchical design of a polymeric nanovehicle for efficient tumor regression and imaging. |
Q38281424 | Hierarchical supramolecules and organization using boronic acid building blocks |
Q42797048 | High-Resolution Imaging of Dendrimers Used in Drug Delivery via Scanning Probe Microscopy |
Q26825654 | Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation |
Q38261727 | Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow |
Q90535493 | In situ real-time tracing of hierarchical targeting nanostructures in drug resistant tumors using diffuse fluorescence tomography |
Q39298704 | In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles |
Q35051682 | In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe |
Q34566500 | Increased tumor distribution and expression of histidine-rich plasmid polyplexes |
Q34426254 | Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers |
Q35119565 | Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles. |
Q37602017 | Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation |
Q38074442 | Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy |
Q89966843 | Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine |
Q33715962 | Intracellular fate of spherical nucleic acid nanoparticle conjugates. |
Q53662412 | Intravital multiphoton imaging of the selective uptake of water-dispersible quantum dots into sinusoidal liver cells. |
Q97595568 | Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo |
Q38211726 | Macrophages associated with tumors as potential targets and therapeutic intermediates |
Q51239630 | Mechanism for the Cellular Uptake of Targeted Gold Nanorods of Defined Aspect Ratios. |
Q42859704 | Metal-Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer Cells |
Q39258510 | Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers |
Q38714911 | Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects |
Q28552659 | Molecular Determinants of the Cellular Entry of Asymmetric Peptide Dendrimers and Role of Caveolae |
Q38537527 | Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine |
Q55265735 | Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment. |
Q35688089 | Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release |
Q39322944 | Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer |
Q47261880 | Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues |
Q51045603 | N-Acetylgalactosamine-Targeted Delivery of Dendrimer-Doxorubicin Conjugates Influences Doxorubicin Cytotoxicity and Metabolic Profile in Hepatic Cancer Cells. |
Q34622662 | Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances |
Q90409762 | Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities |
Q62594020 | Nanomaterials as photothermal therapeutic agents |
Q39022735 | Nanostructural systems developed with positive charge generation to drug delivery |
Q35737878 | Nanotechnology for cancer treatment. |
Q36036029 | Nanotechnology in bladder cancer: current state of development and clinical practice |
Q98197151 | Nanotechnology-based antiviral therapeutics |
Q55265933 | Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C+ monocytes. |
Q64265678 | Noncovalent Complexation of Amphotericin B with Poly(β-Amino Ester) Derivates for Treatment of Infection |
Q38227515 | Noncovalent interaction-assisted polymeric micelles for controlled drug delivery. |
Q50220612 | Novel advances in targeted drug delivery |
Q41634313 | Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer |
Q83230780 | Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide |
Q48473743 | Organ-specific distribution of gold nanoparticles by their surface functionalization |
Q39051329 | PEG-PCL-DEX polymersome-protamine vector as an efficient gene delivery system via PEG-guided self-assembly |
Q34011141 | PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel |
Q35377803 | PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma |
Q57065460 | PEGylation of Superparamagnetic Iron Oxide Nanoparticles with Self-Organizing Polyacrylate-PEG Brushes for Contrast Enhancement in MRI Diagnosis |
Q34733497 | Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy |
Q49628457 | Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors. |
Q35737342 | Peptide Decoration of Nanovehicles to Achieve Active Targeting and Pathology-Responsive Cellular Uptake for Bone Metastasis Chemotherapy. |
Q39007103 | Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy |
Q36028787 | Perspectives on clinical translation of smart nanotherapeutics |
Q28396383 | Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery |
Q33889055 | Photo and redox dual responsive reversibly cross-linked nanocarrier for efficient tumor-targeted drug delivery |
Q38047267 | Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking |
Q33762893 | Polyanhydride micelles with diverse morphologies for shape-regulated cellular internalization and blood circulation |
Q36644318 | Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects. |
Q27346531 | Polyoxazoline multivalently conjugated with indocyanine green for sensitive in vivo photoacoustic imaging of tumors |
Q39119043 | Polypeptide/doxorubicin hydrochloride polymersomes prepared through organic solvent-free technique as a smart drug delivery platform |
Q51740469 | Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. |
Q42917296 | Positively Charged Dendron Micelles Display Negligible Cellular Interactions |
Q40736574 | Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles |
Q64236390 | Preparation and Characterization of PLA-PEG-PLA/PEI/DNA Nanoparticles for Improvement of Transfection Efficiency and Controlled Release of DNA in Gene Delivery Systems |
Q59113598 | Preparation andIn VitroEvaluation of a Multifunctional Iron Silicate@Liposome Nanohybrid for pH-Sensitive Doxorubicin Delivery and Photoacoustic Imaging |
Q55020915 | Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile. |
Q37162182 | Principles of nanoparticle design for overcoming biological barriers to drug delivery |
Q41949821 | Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. |
Q57342738 | Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents |
Q55033763 | Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)-poly(ethylene glycol) for long-term sustained release. |
Q57039785 | Protein-based nanoparticles in Cancer vaccine development |
Q39316957 | Quantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite charge |
Q35062808 | Quantum dot/antibody conjugates for in vivo cytometric imaging in mice |
Q55002491 | Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy. |
Q35100738 | Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells |
Q37733291 | Reduction-triggered breakable micelles of amphiphilic polyamide amine-g-polyethylene glycol for methotrexate delivery |
Q90362515 | Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery |
Q35602780 | Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles |
Q52570980 | Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma. |
Q28394457 | Role of surface charge in determining the biological effects of CdSe/ZnS quantum dots |
Q28534642 | Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation |
Q37000155 | Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice |
Q41997199 | Strategies for the enhanced intracellular delivery of nanomaterials |
Q36316020 | Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials. |
Q30744724 | Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties |
Q51826960 | Suppression of the reticuloendothelial system using λ-carrageenan to prolong the circulation of gold nanoparticles. |
Q47589446 | Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications |
Q93006728 | Systematic Study of a Library of PDMAEMA-Based, Superparamagnetic Nano-Stars for the Transfection of CHO-K1 Cells |
Q38937398 | Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases |
Q38691793 | Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation |
Q49787181 | Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer. |
Q39214348 | Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma |
Q90479600 | Targeting of Hepatic Macrophages by Therapeutic Nanoparticles |
Q57022694 | Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases |
Q36096040 | Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs |
Q35951743 | Targeting polymer therapeutics to bone |
Q37606583 | Telodendrimer-based nanocarriers for the treatment of ovarian cancer |
Q90411487 | The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target |
Q92240603 | The Physicochemical Properties of Graphene Nanocomposites Influence the Anticancer Effect |
Q48147687 | The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles |
Q39294250 | The effect of metal-chelating polymers (MCPs) for 111In complexed via the streptavidin-biotin system to trastuzumab Fab fragments on tumor and normal tissue distribution in mice |
Q42370576 | The new era of nanotechnology, an alternative to change cancer treatment |
Q38672028 | Toward the suppression of cellular toxicity from single-walled carbon nanotubes |
Q34343298 | Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. |
Q55456813 | Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends. |
Q36459188 | Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. |
Q57347678 | Upconversion nanophosphors for use in bioimaging, therapy, drug delivery and bioassays |
Q49389681 | Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings |
Q35804205 | Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy. |
Q35301495 | Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine |
Q39410737 | Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols |
Q35108788 | Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery |
Search more.